Extract: Plasminogen-activator activity was measured in lungs from 7 newborn premature infants examined at autopsy (control lungs) and 11 infants dying of hyaline membrane disease (hyaline membrane ...

In 2001, the US Food and Drug Administration approved recombinant tissue plasminogen activator (alteplase, Cathflo Activase) to reestablish patency of central catheters occluded, presumably, by a ...

A new analysis supports the use of intravenous (IV) tenecteplase over IV alteplase (tissue plasminogen activator) for treatment of acute ischemic stroke. The analysis found that patients with ischemic ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — A tissue plasminogen activator and pneumatic displacement of submacular hemorrhage offered nearly a 90% ...

Adult patients with sickle cell disease who experience a stroke caused by a clot (i.e., ischemic strokes) can be treated safely with tissue plasminogen activator if they qualify, report investigators.

Amerigo Scientific, a distribution company focused on providing critical products and services to the biomedical and life science research communities, now introduces Tissue Plasminogen Activator for ...

New Rochelle, NY, June 19, 2014—Plasminogen activators are proteins involved in the breakdown of blood clots, and an elevated level of plasminogen activator inhibitor-1 (PAI-1) is associated with an ...

TISSUE PLASMINOGEN ACTIVATOR (TPA) INJECTED INTRAVENOUSLY within 3 hours of symptom onset has emerged as a treatment option for acute ischemic stroke. Although controversial and not universally ...

Proceedings of the National Academy of Sciences of the United States of America, Vol. 87, No. 5 (Mar., 1990), pp. 1865-1869 (5 pages) Heparin stimulates the activity of tissue plasminogen activator (t ...